Safety of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma following Transarterial Radioembolization vs. Transarterial Chemoembolization

被引：0
|
作者：
Hardy, C. [1 ]
Lazarev, S. [2 ]
Ru, M. [3 ]
Moshier, E. [1 ]
Rosenzweig, K. [1 ]
Buckstein, M. [2 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA
[3] Mt Sinai Hosp, New York, NY 10029 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SU_13_2129
引用
收藏
页码：E54 / E54
页数：1
相关论文
共 50 条
  • [21] Combined Transarterial Chemoembolization (TACE) and Stereotactic Body Radiation Therapy (SBRT) for Management of Primary Hepatocellular Carcinoma (HCC)
    Blacksburg, S. R.
    Zhang, E.
    Liu, J.
    Facciuto, M.
    Roayaie, S.
    Schwartz, M.
    Lookstein, R.
    Kim, E.
    Rosenzweig, K. E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S319 - S319
  • [22] TRANSARTERIAL CHEMOEMBOLIZATION VERSUS TRANSARTERIAL RADIOEMBOLIZATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
    Brown, Andrew
    Kassab, Ihab A.
    Chen, Vincent L.
    Townsend, Whitney A.
    Singal, Amit G.
    Parikh, Neehar D.
    [J]. HEPATOLOGY, 2019, 70 : 234A - 235A
  • [23] Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality
    Kim, Do Young
    Han, Kwang-Hyub
    [J]. HEPATOLOGY INTERNATIONAL, 2016, 10 (06) : 883 - 892
  • [24] Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) as a Bridge to Transplant in Unresectable Hepatocellular Carcinoma
    Verbus, Emily A.
    Rossi, Alexander J.
    Teke, Martha
    Nugent, Francis W.
    Hernandez, Jonathan M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (01) : 33 - 34
  • [25] Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization
    Kang, Jin-Kyu
    Kim, Mi-Sook
    Cho, Chul Koo
    Yang, Kwang Mo
    Yoo, Hyung Jun
    Kim, Jin Ho
    Bae, Sun Hyun
    Jung, Da Hoon
    Kim, Kum Bae
    Lee, Dong Han
    Han, Chul Ju
    Kim, Jin
    Park, Su Cheol
    Kim, Young Han
    [J]. CANCER, 2012, 118 (21) : 5424 - 5431
  • [26] A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination With Transarterial Chemoembolization for Hepatocellular Carcinoma
    Sebastian, Nikhil T.
    Miller, Eric D.
    Yang, Xiangyu
    Diaz, Dayssy Alexandra
    Tan, Yubo
    Dowell, Joshua
    Spain, James
    Rikabi, Ali
    Elliott, Eric
    Knopp, Michael
    Williams, Terence M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (05): : 1276 - 1283
  • [27] Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality
    Do Young Kim
    Kwang-Hyub Han
    [J]. Hepatology International, 2016, 10 : 883 - 892
  • [28] Efficacy and Safety of Intensity Modulated Radiation Therapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
    Zhao, Y.
    Wang, W. H.
    Li, Y. X.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E137 - E137
  • [29] Ruptured Hepatocellular Carcinoma following Transarterial Radioembolization
    Smith, Jason C.
    Nasiri, Arian
    Fujimoto, Scott
    Volk, Michael
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 29 (09) : 1302 - 1305
  • [30] Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Dumago, Mark P.
    Agas, Ryan Anthony F.
    Jainar, Carl Jay E.
    Yap, Eugene T.
    Co, Lester Bryan A.
    Ortin, Teresa T. Sy
    [J]. JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (04) : 1058 - 1070
12345